Scott Adler

2.4k total citations
39 papers, 1.9k citations indexed

About

Scott Adler is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Scott Adler has authored 39 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Nephrology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Surgery. Recurrent topics in Scott Adler's work include Gout, Hyperuricemia, Uric Acid (7 papers), Potassium and Related Disorders (5 papers) and Acute Kidney Injury Research (4 papers). Scott Adler is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (7 papers), Potassium and Related Disorders (5 papers) and Acute Kidney Injury Research (4 papers). Scott Adler collaborates with scholars based in United States, Australia and Germany. Scott Adler's co-authors include Warren S. Pear, Ivan Maillard, Nihar Bhakta, Chris Storgard, Maple M. Fung, Jeff Kopicko, Scott Baumgartner, Laurence A. Turka, Paul E. Klotman and Leslie A. Bruggeman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Immunity.

In The Last Decade

Scott Adler

37 papers receiving 1.8k citations

Peers

Countries citing papers authored by Scott Adler

Since Specialization

Citations

This map shows the geographic impact of Scott Adler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Adler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Adler more than expected).

Fields of papers citing papers by Scott Adler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Adler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Adler. The network helps show where Scott Adler may publish in the future.

Co-authorship network of co-authors of Scott Adler

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Adler. A scholar is included among the top collaborators of Scott Adler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Adler. Scott Adler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Urinary Kidney Injury Biomarker Profiles in Healthy Individuals and After Nephrotoxic and Ischemic Injury 2025 ·Clinical Pharmacology & Therapeutics ·Sushrut S. Waikar, Robin Mogg, Amanda F. Baker, György Frendl, Michael J. Topper, Scott Adler, Stefan Sultana, (unknown), Nicholas M. P. King, Steven P. Piccoli, (unknown), (unknown), Irene Nunes, Frank D. Sistare	4
2	12520 Preliminary Findings From An Ongoing Open-label Phase 2 Study Demonstrate That The Calcilytic Encaleret Can Improve The Relationship Between Blood And Urinary Calcium In Individuals With Post-surgical Hypoparathyroidism 2024 ·Journal of the Endocrine Society ·Ian R. Hartley, Rachel I. Gafni, Kelly L. Roszko, Xiaorong Li, (unknown), Cynthia A. Moore, (unknown), (unknown), Arani Sridhar, (unknown), Mary Scott Roberts, Scott Adler, Edward F. Nemeth, Michael T. Collins	1
3	OR23-03 Sustained Normalization Of Mineral Homeostasis In Autosomal Dominant Hypocalcemia Type 1: Results From A Phase 2 Study Over 18 Months Of Encaleret (CLTX-305) Treatment (NCT04581629) 2023 ·Journal of the Endocrine Society ·Rachel I. Gafni, Iris R. Hartley, Kelly L. Roszko, Edward F. Nemeth, (unknown), (unknown), Mary Scott Roberts, Scott Adler, Michael T. Collins	0
4	Anti‐interleukin‐6 antibody clazakizumab in late antibody‐mediated kidney transplant rejection: effect on cytochrome P450 drug metabolism 2021 ·Transplant International ·Jakob Mühlbacher, Christian Schörgenhofer, Konstantin Doberer, Michael Dürr, Klemens Budde, Farsad Eskandary, Katharina A. Mayer, Sabine Schranz, Sarah Ely, Birgit Reiter, Edward Chong, Scott Adler, Bernd Jilma, Georg A. Böhmig	7
5	Abstract 16610: Efficacy and Safety of Sodium Zirconium Cyclosilicate to Treat Hyperkalemia Among Patients Taking Renin-Angiotensin-Aldosterone System Inhibitors in a 12-Month, Open-Label, Phase 3 Study: A Post Hoc Subgroup Analysis 2017 ·Circulation ·P. R. McCullough, Pablo E. Pérgola, Steven Fishbane, Stephan von Haehling, Simon D. Roger, Scott Adler, Bhupinder Singh, Philip T. Lavin, Javed Butler, Geoffrey A. Block, Edgar V. Lerma, David Packham, Mikhail Kosiborod	2
6	Lesinurad monotherapy in gout patients intolerant to a xanthine oxidase inhibitor: a 6 month phase 3 clinical trial and extension study 2017 ·Lara D. Veeken ·Anne‐Kathrin Tausche, Rieke Alten, Nicola Dalbeth, Jeff Kopicko, Maple M. Fung, Scott Adler, Nihar Bhakta, Chris Storgard, Scott Baumgartner, Kenneth G. Saag	88
7	Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study) 2016 ·Annals of the Rheumatic Diseases ·Thomas Bardin, Robert T. Keenan, Puja Khanna, Jeff Kopicko, Maple M. Fung, Nihar Bhakta, Scott Adler, Chris Storgard, Scott Baumgartner, Alexander So	126
8	Nephropathy in HIV-Transgenic Mice 2015 ·Contributions to nephrology ·Jeffrey B. Kopp, Patricio E. Ray, Scott Adler, Leslie A. Bruggeman, Christina Mangurian, Jennie W. Owens, Michael Eckhaus, Joseph Bryant, Paul E. Klotman	3
9	FRI0333 Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination with Allopurinol: Results from a Phase III Study in Gout Patients Having an Inadequate Response to Standard of Care (Clear 2) 2015 ·Annals of the Rheumatic Diseases ·Thomas Bardin, Robert T. Keenan, Puja Khanna, Jeff Kopicko, Maple M. Fung, Nihar Bhakta, Scott Adler, Chris Storgard, Scott Baumgartner, Alexander So	8
10	Detecting esophageal disease with second-generation capsule endoscopy: initial evaluation of the PillCam ESO 2 2008 ·Endoscopy ·(unknown), Scott Adler, K. Yassin, Benjamin Koslowsky, Y. Metzger, Rami Eliakim	47
11	An open‐label, pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in established renal allograft recipients with moderate renal insufficiency 2004 ·Clinical Transplantation ·V. Ram Peddi, Stephen C. Jensik, Mark D. Pescovitz, John D. Pirsch, Scott Adler, J. Richard Thistlethwaite, Flavio Vincenti, David J. Cohen	38
12	Notch Signaling Augments T Cell Responsiveness by Enhancing CD25 Expression 2003 ·The Journal of Immunology ·Scott Adler, Elise Chiffoleau, Lanwei Xu, (unknown), Jennifer M. Burg, Andrew D. Wells, Michael S. Wolfe, Laurence A. Turka, Warren S. Pear	180
13	Incomplete Activation of CD4 T Cells by Antigen-Presenting Transitional Immature B Cells: Implications for Peripheral B and T Cell Responsiveness 2003 ·The Journal of Immunology ·James Chung, Andrew D. Wells, Scott Adler, Anand Jacob, Laurence A. Turka, John G. Monroe	39
14	Bcl-XL Expression in Stem Cells Facilitates Engraftment and Reduces the Need for Host Conditioning During Bone Marrow Transplantation 2003 ·American Journal of Transplantation ·Marielena Mata, Elise Chiffoleau, Scott Adler, (unknown), Wayne W. Hancock, Laurence A. Turka	9
15	Notch and the Immune System 2003 ·Immunity ·Ivan Maillard, Scott Adler, Warren S. Pear	180
16	Nuclear factor-κB binding to the HIV-1 LTR in kidney: Implications for HIV-associated nephropathy 2001 ·Kidney International ·Leslie A. Bruggeman, Scott Adler, Paul E. Klotman	18
17	New models to define factors determining the growth and spread of human prostate cancer 1992 ·Experimental Gerontology ·Antonino Passaniti, Scott Adler, George R. Martin	5
18	Characterization of glomerular epithelial cell matrix receptors. 1992 ·PubMed ·Scott Adler	97
19	Laminin in Neuronal Development 1990 ·Annals of the New York Academy of Sciences ·Hynda K. Kleinman, Gregory C. Sephel, Ken‐ichiro Tashiro, Benjamin S. Weeks, (unknown), Scott Adler, Yoshihiko Yamada, George R. Martin	52
20	Negative ion chemical ionization mass spectrometry of deoxynivalenol (DON): application to identification of DON in grains and snack foods after quantitation/isolation by thin-layer chromatography 1985 ·Journal of Agricultural and Food Chemistry ·William C. Brumley, Mary W Trucksess, Scott Adler, (unknown), Kevin D. White, James A. Sphon	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact